Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Targeting Receptor-Mediated Transport for Delivery of Biologics Across the Blood-Brain Barrier.
Paroxysmal dysarthria-ataxia syndrome resolving after fingolimod treatment.
MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study.
Validation of a Dutch version of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis: an observational web-based study.
Rotarod motor performance and advanced spinal cord lesion image analysis refine assessment of neurodegeneration in experimental autoimmune encephalomyelitis.
Calreticulin and other components of endoplasmic reticulum stress in rat and human inflammatory demyelination.
Effect of occupation on risk of developing MS: an insurance cohort study.
Teva to present further results of twenty-year open-label extension study of glatiramer acetate 20 mg daily for relapsing-remitting multiple sclerosis
The plasminogen activator system: involvement in central nervous system inflammation and a potential site for therapeutic intervention.
Optic neuritis revealing Kikuchi-Fujimoto's disease: clinical commentary.
Investigation of gene-gene interactions between CD40 and CD40L in Polish multiple sclerosis patients.
Current symptomatology in multiple sclerosis and neuromyelitis optica.
Alterations in nerve-evoked bladder contractions in a coronavirus-induced mouse model of multiple sclerosis.
Goals set after completing a teleconference-delivered program for managing multiple sclerosis fatigue.
Intrathecal BCR transcriptome in multiple sclerosis versus other neuroinflammation: Equally diverse and compartmentalized, but more mutated, biased and overlapping with the proteome.
Modern communication technology skills of patients with multiple sclerosis.
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.
Exposure to UV Wavelengths in Sunlight Suppresses Immunity. To What Extent is UV-induced Vitamin D3 the Mediator Responsible?
Cardiac stunning as first manifestation of multiple sclerosis: A case report reminding us not to overlook cardiovascular autonomic dysfunction in multiple sclerosis.
No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1a therapy in relapsing-remitting multiple sclerosis (the ARIANNA study).
Presynaptic, release-regulating mGlu2-preferring and mGlu3-preferring autoreceptors in CNS: pharmacological profiles and functional roles in demyelinating disease.
Role of inflammation and apoptosis in multiple sclerosis: Comparative analysis between the periphery and the central nervous system.
Prevalence of neuropathic pain in early multiple sclerosis.
Inequalities In Access to Treatment for Multiple Sclerosis In England Continue Despite Service Improvement Initiatives And Policy Reforms.
Myelinated mouse nerves studied by X-ray phase contrast zoom tomography.

Pages